These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35240973)

  • 21. Supramolecular Organization As a Factor of Ribonuclease Cytotoxicity.
    Dudkina EV; Ulyanova VV; Ilinskaya ON
    Acta Naturae; 2020; 12(3):24-33. PubMed ID: 33173594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribonucleases and their antitumor activity.
    Matousek J
    Comp Biochem Physiol C Toxicol Pharmacol; 2001 Jul; 129(3):175-91. PubMed ID: 11461835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells.
    Fagagnini A; Pica A; Fasoli S; Montioli R; Donadelli M; Cordani M; Butturini E; Acquasaliente L; Picone D; Gotte G
    Biochem J; 2017 Nov; 474(22):3767-3781. PubMed ID: 28963346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of electrostatic interactions in the antitumor activity of dimeric RNases.
    Notomista E; Mancheño JM; Crescenzi O; Di Donato A; Gavilanes J; D'Alessio G
    FEBS J; 2006 Aug; 273(16):3687-97. PubMed ID: 16911519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribonucleases of different origins with a wide spectrum of medicinal applications.
    Fang EF; Ng TB
    Biochim Biophys Acta; 2011 Jan; 1815(1):65-74. PubMed ID: 20843477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular routing of cytotoxic pancreatic-type ribonucleases.
    Benito A; Vilanova M; Ribó M
    Curr Pharm Biotechnol; 2008 Jun; 9(3):169-79. PubMed ID: 18673282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the intracellular routing of cytotoxic ribonucleases.
    Wu Y; Saxena SK; Ardelt W; Gadina M; Mikulski SM; De Lorenzo C; D'Alessio G; Youle RJ
    J Biol Chem; 1995 Jul; 270(29):17476-81. PubMed ID: 7542240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer.
    Liu D; Cardillo TM; Wang Y; Rossi EA; Goldenberg DM; Chang CH
    Mol Cancer; 2014 Mar; 13():53. PubMed ID: 24606732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribonucleases as novel chemotherapeutics : the ranpirnase example.
    Lee JE; Raines RT
    BioDrugs; 2008; 22(1):53-8. PubMed ID: 18215091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis.
    Iordanov MS; Ryabinina OP; Wong J; Dinh TH; Newton DL; Rybak SM; Magun BE
    Cancer Res; 2000 Apr; 60(7):1983-94. PubMed ID: 10766189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies.
    Beck AK; Pass HI; Carbone M; Yang H
    Future Oncol; 2008 Jun; 4(3):341-9. PubMed ID: 18518759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer chemotherapy--ribonucleases to the rescue.
    Leland PA; Raines RT
    Chem Biol; 2001 May; 8(5):405-13. PubMed ID: 11358688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of cytotoxic ribonucleases by cationization to enhance intracellular protein delivery.
    Futami J; Yamada H
    Curr Pharm Biotechnol; 2008 Jun; 9(3):180-4. PubMed ID: 18673283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ribonucleases and angiogenins from fish.
    Pizzo E; Buonanno P; Di Maro A; Ponticelli S; De Falco S; Quarto N; Cubellis MV; D'Alessio G
    J Biol Chem; 2006 Sep; 281(37):27454-60. PubMed ID: 16861230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ribonucleases in tumor growth.
    Shlyakhovenko VA
    Exp Oncol; 2009 Sep; 31(3):127-33. PubMed ID: 19783970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression.
    Bedoya VI; Boasso A; Hardy AW; Rybak S; Shearer GM; Rugeles MT
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):897-907. PubMed ID: 16989616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ranpirnase (Onconase), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy.
    Lee I
    Expert Opin Biol Ther; 2008 Jun; 8(6):813-27. PubMed ID: 18476793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of antitumor effects of leczymes.
    Tatsuta T; Hosono M
    Glycoconj J; 2022 Apr; 39(2):157-165. PubMed ID: 35066741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells.
    Jordaan S; Akinrinmade OA; Nachreiner T; Cremer C; Naran K; Chetty S; Barth S
    Biomedicines; 2018 Mar; 6(1):. PubMed ID: 29510557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A ribonuclease inhibitor resistant dimer of human pancreatic ribonuclease displays specific antitumor activity.
    Attery A; Dey P; Tripathi P; Batra JK
    Int J Biol Macromol; 2018 Feb; 107(Pt B):1965-1970. PubMed ID: 29042278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.